Saturday 17 October 2026
Export TFX’s income statement to Excel — free account
Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 28.9%, EPS fell 17.3%, free cash flow grew 220.1% and total debt rose 47.7%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
130.43
2.21
+1.72%
Follow TFX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 122.74 | 33.04 | 32.24 | 31.68 | 57.00 | 37.68 | 58.88 | 75.36 | 28.99 |
Piotroski F-Score |
5 | 6 | 3 | 5 | 7 | 4 | 7 | 5 | 4 | 6 |
P/S ratio |
2.73 | 4.90 | 6.87 | 4.20 | 5.47 | 7.54 | 6.70 | 4.82 | 5.34 | 3.68 |
Altman Z-Score |
2.04 | 3.01 | 3.50 | 3.97 | 4.47 | 4.31 | 4.53 | 3.12 | 2.98 | 4.16 |
Altman Z″-Score (non-manufacturers) |
3.56 | 4.34 | 4.21 | 4.52 | 4.17 | 3.54 | 3.62 | 3.00 | 2.98 | 4.94 |
P/FCF ratio |
3,766.02 | 39.42 | 73.67 | 44.45 | 26.47 | 55.23 | 49.87 | 33.33 | 32.26 | 19.25 |
Beneish M-Score |
(2.21) | (3.15) | (2.17) | (2.37) | (2.61) | (2.57) | (2.32) | (2.60) | (2.49) | (2.68) |
P/Operating CF |
(59.01) | (62.33) | (70.78) | 119.09 | 76.18 | 97.79 | 117.59 | 89.37 | 107.55 | 63.15 |
Dividend Safety Score |
20 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.74 | 1.95 | 2.65 | 2.91 | 4.09 | 5.73 | 5.84 | 4.65 | 4.72 | 3.22 |
Price to Tangible BV |
0.00 | 8.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.87 | 5.73 | 7.80 | 4.71 | 5.97 | 8.37 | 7.32 | 5.56 | 6.23 | 3.95 |
EV/EBITDA |
25.63 | 36.28 | 32.92 | 17.89 | 21.53 | 32.43 | 29.71 | 25.37 | 25.12 | 16.47 |
EV/Operating CF |
79.73 | 32.28 | 64.80 | 38.32 | 25.71 | 48.58 | 43.47 | 31.28 | 31.39 | 17.96 |
EV/FCF |
5,330.95 | 46.08 | 83.64 | 49.83 | 28.89 | 61.30 | 54.48 | 38.42 | 37.65 | 20.63 |
Quick Ratio |
0.95 | 0.73 | 1.10 | 1.21 | 1.22 | 1.43 | 1.28 | 1.24 | 1.40 | 1.91 |
Current Ratio |
2.54 | 2.27 | 2.32 | 2.43 | 2.10 | 2.63 | 2.32 | 2.12 | 2.33 | 2.77 |
Net Debt/EBITDA |
7.52 | 5.24 | 3.92 | 1.93 | 1.80 | 3.21 | 2.51 | 3.36 | 3.60 | 1.10 |
Debt/Assets |
38.02% | 23.33% | 24.10% | 24.70% | 26.92% | 34.65% | 30.25% | 34.39% | 36.39% | 26.60% |
Debt/Equity |
0.85 | 0.39 | 0.41 | 0.43 | 0.49 | 0.74 | 0.64 | 0.85 | 0.93 | 0.48 |
Asset Turnover |
0.28 | 0.23 | 0.24 | 0.40 | 0.40 | 0.38 | 0.41 | 0.39 | 0.43 | 0.48 |
Operating CF/Net income |
(0.11) | 4.33 | 0.58 | 0.94 | 1.34 | 1.30 | 0.95 | 2.17 | 2.79 | 1.73 |
Capex/Depreciation |
(0.52) | (0.55) | (0.31) | (0.34) | (0.30) | (0.39) | (0.40) | (0.38) | (0.44) | (0.41) |
Interest Coverage |
1.18 | 1.24 | 2.99 | 9.21 | 9.43 | 6.36 | 5.25 | 3.12 | 4.51 | 5.81 |
| (24.47%) | 1.60% | 8.42% | 9.34% | 13.69% | 10.62% | 16.72% | 8.08% | 6.68% | 11.44% | |
| (12.90%) | 0.95% | 4.93% | 5.26% | 6.92% | 4.98% | 7.33% | 3.22% | 3.03% | 6.12% | |
ROIC |
1.37% | 1.14% | 2.63% | 5.74% | 6.50% | 4.86% | 5.74% | 4.63% | 5.35% | 7.59% |
Return on Tangible Assets |
(54.08%) | 6.16% | 27.83% | 28.44% | 40.69% | 24.72% | 39.31% | 18.48% | 14.84% | 22.42% |
Average Days of Receivables |
63.30 | 48.69 | 94.52 | 53.47 | 49.83 | 56.84 | 58.88 | 54.61 | 58.82 | 53.15 |
Research and Development Expense of Revenue |
7.27% | 6.41% | 6.64% | 5.51% | 4.66% | 4.72% | 4.39% | 4.34% | 3.95% | 3.14% |
Selling, General and Administrative Expense of Revenue |
36.14% | 39.69% | 36.37% | 30.95% | 30.61% | 29.31% | 32.82% | 32.55% | 32.61% | 30.16% |
Intangible Assets out of Total Assets |
0.55 | 0.47 | 0.72 | 0.70 | 0.70 | 0.71 | 0.70 | 0.73 | 0.75 | 0.61 |
Share Based Compensation of Revenue |
1.29% | 1.53% | 1.59% | 0.98% | 0.82% | 0.82% | 1.04% | 0.92% | 0.90% | 0.90% |
Graham Net Nets |
(0.35) | (0.16) | (0.14) | (0.13) | (0.11) | (0.13) | (0.12) | (0.21) | (0.23) | (0.08) |
Graham Number |
0.00 | 54.59 | 126.97 | 122.29 | 136.86 | 107.98 | 120.40 | 74.10 | 64.09 | 78.00 |
Earnings Yield |
(16.83%) | 0.81% | 3.03% | 3.10% | 3.16% | 1.75% | 2.65% | 1.70% | 1.33% | 3.45% |
Free Cash Flow Yield |
0.03% | 2.54% | 1.36% | 2.25% | 3.78% | 1.81% | 2.01% | 3.00% | 3.10% | 5.19% |
Revenue per Share |
44.66 | 36.29 | 36.45 | 59.51 | 60.07 | 54.58 | 56.18 | 53.59 | 47.69 | 43.12 |
Operating CF per Share |
2.17 | 6.45 | 4.39 | 7.31 | 13.94 | 9.40 | 9.46 | 9.52 | 9.47 | 9.48 |
Capex per Share |
(2.13) | (1.93) | (0.99) | (1.69) | (1.53) | (1.95) | (1.91) | (1.77) | (1.58) | (1.23) |
Free Cash Flow per Share |
0.03 | 4.51 | 3.40 | 5.62 | 12.41 | 7.45 | 7.55 | 7.75 | 7.90 | 8.25 |
Cash per Share |
8.48 | 5.29 | 4.74 | 6.23 | 9.52 | 8.09 | 6.52 | 7.82 | 7.41 | 12.55 |
Shareholders Equity per Share |
70.03 | 91.34 | 94.53 | 85.76 | 80.27 | 71.77 | 64.49 | 55.59 | 54.01 | 49.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
70.03 | 91.34 | 94.53 | 85.76 | 80.27 | 71.77 | 64.49 | 55.59 | 54.01 | 49.34 |
Free Cash Flow |
1.45 | 211.45 | 159.72 | 263.62 | 580.52 | 346.45 | 348.72 | 354.29 | 355.40 | 357.46 |
Working Capital |
1,176.31 | 821.76 | 800.66 | 829.49 | 749.00 | 882.40 | 743.28 | 653.71 | 644.93 | 755.75 |
Capital Expenditures |
(95.24) | (90.44) | (46.42) | (79.19) | (71.62) | (90.69) | (88.35) | (80.79) | (70.90) | (53.13) |
Net Current Asset Value |
(1,884.13) | (1,348.65) | (1,684.15) | (1,495.11) | (1,687.86) | (2,393.68) | (2,024.17) | (2,501.84) | (2,622.15) | (570.30) |
EV/EBIT |
65.12 | 94.01 | 52.53 | 26.29 | 31.23 | 50.19 | 45.11 | 42.31 | 35.94 | 23.08 |
Capex to Sales |
0.05 | 0.05 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
46.00 | 80.42 | 46.27 | 23.45 | 28.61 | 45.22 | 41.29 | 36.71 | 30.79 | 21.55 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.37 | 0.53 | 0.32 | 0.52 | 0.55 | 0.49 | 0.51 | 0.50 | 0.42 | 0.42 |
Cash ROIC |
0.02% | 3.42% | 2.47% | 4.37% | 9.60% | 5.60% | 6.72% | 7.01% | 7.09% | 9.62% |
Accounts Receivable Turnover |
6.96 | 5.07 | 4.02 | 7.04 | 7.22 | 6.24 | 6.61 | 6.88 | 6.95 | 6.99 |
Accounts Payable Turnover |
7.65 | 5.76 | 5.19 | 10.28 | 11.42 | 11.80 | 11.32 | 11.53 | 12.07 | 12.85 |
Inventory Turnover |
2.45 | 1.42 | 1.12 | 2.39 | 2.54 | 2.45 | 2.62 | 2.78 | 2.74 | 2.70 |
Average Days of Payables |
54.50 | 53.94 | 71.80 | 36.74 | 34.25 | 30.87 | 31.66 | 34.00 | 34.47 | 29.06 |
Days of Inventory on Hand |
169.28 | 169.10 | 339.97 | 167.59 | 138.37 | 154.52 | 146.62 | 136.30 | 148.23 | 132.37 |
Average Receivables |
286.16 | 335.10 | 426.15 | 396.20 | 389.32 | 406.87 | 392.48 | 356.08 | 308.93 | 267.20 |
Average Payables |
114.03 | 115.05 | 129.53 | 122.52 | 110.38 | 102.72 | 104.81 | 99.37 | 80.71 | 67.85 |
Average Inventory |
355.58 | 466.49 | 602.36 | 528.08 | 495.42 | 494.88 | 452.17 | 411.76 | 355.96 | 323.22 |
Average Assets |
7,022.58 | 7,315.23 | 7,230.30 | 6,899.89 | 7,012.14 | 6,731.19 | 6,293.91 | 6,229.74 | 5,036.35 | 3,881.49 |
Average Common Equity |
3,701.45 | 4,359.56 | 4,231.48 | 3,888.36 | 3,545.60 | 3,157.89 | 2,759.65 | 2,485.25 | 2,284.02 | 2,074.31 |
Columns are period end dates · fundamentals updated 1 Oct 2026